DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE (EIN 274482027) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

Phone

8584051277

Tax Period

2023-01-01 to 2023-12-31

DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE, founded in 2010, is a community nonprofit in the Medical Research sector that reported $1.3M in total revenue in fiscal year 2023. Revenue surged 128% from the prior year, signaling strong growth momentum. The organization ran a surplus of $496K, a strong 37% operating margin.

Mission

Deliver new drugs and new diagnostics for diseases that affect predominantly economically vulnerable populations.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,310,080

Program Service Revenue $0

Investment Income $0

Other Revenue $21,487

TOTAL REVENUE $1,331,567

Expense Breakdown

Grants Paid $0

Salaries & Benefits $240,582

Fundraising Expenses $119,345

Program Expenses $613,632

Other Expenses $594,851

TOTAL EXPENSES $835,433

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,331,567	$584,559	+1.3%
Expenses	$835,433	$746,872	+0.1%
Net Income	$496,134	$-162,313	-4.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$44,055

Total Directors

$44,055

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARCO A BIAMONTE	President & CEO	20.00	Officer Director	$39,660	$4,395	$44,055
VISH GAITONDE	Treasurer	1.00	Officer Director	$0	$0	$0
BEVERLY COYNE	Secretary	1.00	Officer Director	$0	$0	$0
JOSH SALISBURY	Director	1.00	Director	$0	$0	$0
MATTHEW WAXMAN	Director	1.00	Director	$0	$0	$0
THOMAS BLACKSHAW	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,331,567	$835,433	$733,464	$496,134
2022	$584,559	$746,872	$243,205	$-162,313
2021	$618,124	$738,573	$391,460	$-120,449
2020	$779,385	$674,983	$518,051	$104,402
2019	$725,745	$303,679	$407,541	$422,066
2018	$98,011	$256,402	$145,651	$-158,391

DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE